Scope: The impact of dietary protein types on the gut microbiome is scarcely studied. The aim of the present study is therefore to examine the effects of lean-seafood and non-seafood proteins on the gut microbiome composition and activity and elucidate potential associations to cardiovascular disease (CVD) risk factors. Methods: A crossover intervention study in which 20 healthy subjects consumed two diets that varied in protein source was conducted.
Introduction
The human gut harbors a diverse and dynamic microbial ecosystem. This ecosystem provides the host with an expanded repertoire of enzymes to digest and metabolize food and thereby expand the human metabolic capacity to form a more diverse array of metabolites including short-chain fatty acids (SFCAs), amino acids, and vitamins. [1] Moreover, the considerable interindividual variation in the gut microbiota composition is anticipated to result in different capacities and outcomes in the utilization of dietary components. [2] There is a growing recognition of the role of diet and other environmental factors in modulating the composition and metabolic activity of the human gut microbiota, which in turn can have a profound effect on overall health. [3, 4] Dietary changes have been associated with changes in the gut microbiome, [5, 6] and the influence of different dietary patterns on microbiota composition has become an area of growing interest. Carbohydrates are possibly the most well-studied component for their ability to modulate the gut microbiome. Randomized controlled www.advancedsciencenews.com www.mnf-journal.com trials evaluating the effect of dietary fiber and prebiotic consumption on the composition and function of the human gut microbiota show examples of diverse responses related to intake of different types of dietary fibers, [7] primarily modulating the microbiota composition and the production of short-chain fatty acids [8, 9] reflecting the dynamic interplay between the host and the gut microbiota. In relation to dietary protein, Zhu et al. [10] recently showed that rats fed with proteins from beef, pork, chicken, fish, casein, and soy, respectively, exhibited significant differences in the microbiota composition according to the protein type. Furthermore, distinct gut bacteria profiles have also been observed in vegetarians and omnivores. [6, 11] Thus, current evidence suggests that protein source influences the gut microbiome. However, limited data are available on the effect of type of dietary protein on the human gut microbiome. Protein, peptides, and amino acids that escape digestion and absorption will enter the large intestine for further fermentation by the gut bacteria, and an interest in the utilization and metabolism of amino acids by gut bacteria as well as the significance of these biochemical processes on the host health has emerged. [12] Based on the differences in amino acid composition, it has been speculated that proteins originating from different dietary origin can exert diverse metabolic effects. [13] Beaumont et al. recently investigated the effect of quantity and type of dietary protein on the gut metabolite production, and they observed a shift toward amino acid metabolism upon ingestion of high protein diets with casein and soy protein. [14] However, Beaumont et al. did not include fish or meat proteins. In the present study, we used a combination of 1 H NMR spectroscopy and 16S rDNA sequencing analyses to investigate the impact of a 4-week dietary intervention with lean-seafood and non-seafood protein sources on fecal metabolite changes and on the gut microbiota composition in healthy humans. Previously, we have reported data from this intervention in which we showed that dietary protein sources differentially modulated risk factors for cardiovascular disease (CVD) including serum triacylglycerol (TAG) and the total to high-density lipoprotein (HDL) cholesterol ratio. Thus, in the present study, we aimed to examine the correlations between these CVD risk factors and the 16S rDNA sequencing information in order to evaluate the contribution of the gut microbiota on health. Furthermore, our aim was to identify characteristic gut microbiota profiles associated with circulating TMAO, which is a metabolite receiving considerable attention due to its proposed role in cardiovascular disease risk. [15] 2. Experimental Section
Study Design
The experimental design has been described previously by Aadland et al. [16] Briefly, as outlined previously, [17] a controlled, randomized study with crossover design including two 4-week experimental periods separated by a 5-week washout period was conducted (Supporting Information Figure 1 ). Prior to each experimental period, participants followed a prudent diet formulated in accordance with the Norwegian nutrition recommendations [18] for 3 weeks (run-in period). After the first 3-week run-in period, half of the subjects were randomly assigned to either the leanseafood diet with lunch and dinner meals including cod, pollack, saithe, and scallops and the other half of the subjects to a non-seafood diet containing chicken, lean beef, turkey, pork, egg, milk, and milk products. After the washout period, the two groups switched to the other diet.
Subjects
The recruitment of human subjects and the participants' physical and clinical characteristics have previously been described by Aadland et al. [16] Briefly, as summarized previously, [17] a total of 148 female and male subjects (aged 18-65) were recruited from the area of Bergen, Norway, of which healthy subjects, assessed by medical examination and fasting blood analysis, were included in the study. Twenty-seven subjects started the study, 20 subjects completed the first diet period, and 19 subjects (7 men and 12 women) completed the study. A total of 8 of 27 subjects dropped out of the study, however this was accounted for in the power calculation before the start of the study. The sample size required in order for fish protein to reduce circulating VLDL triacylglycerol was calculated by Aadland et al., [16] and a minimum of 16 subjects was needed to detect a treatment difference of 25-30% in VLDL triacylglycerol at a probability level inferior to 0.05 and a power level corresponding to 80%. Each participant signed written informed consent and the study protocol was approved by the Regional Committees for Medical and Health Research Ethics of Western Norway (Reference #2012/1084). The study was registered at www.ClinicalTrials.gov (NCT01708681).
Diets
The two experimental diets were given as 7-day rotating menus as described by Aadland et al. [16] Briefly, as given previously, [17] the diets were balanced with equivalent amounts of dietary fiber, carbohydrates, protein, lipids, and monounsaturated, polyunsaturated, and saturated fatty acids. To balance for the n-3 fatty acids present in the lean-seafood diets, cod liver oil was added to all non-seafood dinner meals prior to serving. The protein intake from the experimental protein sources corresponded to 60% of total protein in both diets. The remaining dietary proteins were of vegetable and cereal origins. The subjects were given calcium supplement daily; 750 mg during the lean-seafood intervention and 500 mg during the non-seafood intervention in order to fulfill adequate intakes for both diet groups. In order to fulfill the Nordic recommendation for vitamin D intake supplements (10 μg or 400 IU), vitamin D 3 was given daily during the leanseafood intervention since no milk or milk products were incorporated in that diet. The mean nutritional composition and the amino acid composition of the experimental diets are provided by Aadland et al. [16] Subjects consumed their breakfasts, evening meal, and snacks at home from an approved food list adjusted to their experimental diet and energy level. Subjects were instructed not to consume any food besides the provided prepared meals they were given, or the amount and type of foods included in the breakfast, evening meal, and snack lists.
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Data Acquisition and Preprocessing

Sample Collection and Preparation
Fecal and fasting serum samples were collected before and after each diet period. The fecal samples were collected by the subjects themselves at home, stored refrigerated until arrival at the clinic and subsequently stored at −80°C until analysis. Prior to analysis, the fecal samples were placed at room temperature for 30 min to thaw. Approximately 1 gram of feces was diluted three times in 0.75 M phosphate buffer in a 15 mL Falcon tube and vortex-mixed until homogeneity. The samples were centrifuged (6300 rpm for 15 min) in a Sorvall Centrifuge (Sorvall RC-5B Plus, Dupont, Wilmington, USA), and from the supernatant 1.5 mL fecal water was transferred to a 1.5 mL Eppendorf tube and centrifuged (20 000 × g for 15 min at 4°C). The supernatant were transferred to a new 1.5 mL Eppendorf tube and a second cycle of centrifugation (20 000 × g for 15 min at 4°C) was conducted. An aliquot of 500 μL of fecal water was mixed with 100 μL D 2 O with 0.05% TSP in a 5 mm high-resolution NMR tube.
Fasting serum samples were collected at the clinic by technicians and stored at −80°C until analysis. Upon complete thaw, 300 μL of serum was transferred to a 5 mm NMR tube and mixed with 300 μL D 2 O.
NMR Metabolite Profiling
All fecal NMR spectra were recorded at 298 K on a Bruker Avance 600 spectrometer operating at a 1 H NMR frequency of 600.13 MHz and equipped with a 5 mm TXI probe (Bruker BioSpin, Rheinstetten, Germany). A standard Bruker noesypr1d sequence with water suppression was applied and a total of 64 scans were collected into 32 K data points spanning a spectral width of 12.14 ppm. The 1 H NMR spectra were referenced to the TSP signal at 0 ppm and phase and baseline corrected manually using Topspin 3.0 (Bruker BioSpin). Assignment of the 1 H NMR signals was performed using Chenomx NMR Suite (Chenomx Inc., Canada), the Human Metabolome Database, and literature. [19, 20] In addition, heteronuclear single quantum coherence (HSQC) 2D NMR was applied in a pooled fecal sample to confirm the assignment of signals. The HSQC experiment was acquired with a spectral width of 12.14 ppm in the 1 H dimension and 165.64 ppm in the 13 C dimension and a relaxation delay of 1.5 s.
All serum 1 H NMR spectra were recorded at 310 K using the Carr-Purcell-Meiboom-Gill pulse sequence with water suppression. A total of 64 scans were collected into 32 K data points with a relaxation delay of 2 s. All spectra were acquired with the same receiver gain. The NMR spectra were phased and baseline corrected using TopSpin 3.0 software (Bruker BioSpin).
Bacterial 16S rDNA Sequencing
Bacterial DNA from fecal samples was extracted using the NucleoSpin soil kit from Macherey-Nagel, according to the manufacturer's instructions. PCR-based library formation of the 16S rDNA V4 region was performed with 10 ng of bacterial 
Analysis of Fecal Metabolites
Prior to analysis, the fecal spectral data were normalized to unit area to compensate for differences in water content. Initially, a multivariate model was calculated using SIMCA 15.0 (Umetrics, Umeå, Sweden). However, it was not possible to establish a multivariate model to identify changes in the fecal metabolome between the diets. Thus, we did variable selection based on previously published literature in which metabolites related to gut microbiota activity have been identified. [21, 22] Furthermore, due to the high content of TMAO present in the lean-seafood diet, metabolites related to TMAO metabolism were also included. The selected peaks observed in the fecal 1 H NMR spectra were integrated using an in-house MATLAB script (MATLAB R2009a). A linear mixed-effects model was calculated for each integrated metabolite using the lme4 and pbkrtest packages in R (https://cran.r-project.org/). The model included the fixed effects of diet, gender, period, carryover, the diet-period and diet-gender interactions, and random effects of subject. The model calculated for the postprandial plasma data included an additional effect of the diet-period-time three-way interaction. For testing statistical significance, the full model was compared to a reduced model without the effects in question, and effects with p < 0.05 were considered statistically significant.
Pearson Correlations
The Pearson correlations were calculated using the corrcoef function with t-test in MATLAB combined with Bonferroni-Holm corrections for multiple comparisons. Pearson correlation coefficients with p < 0.05 were considered statistically significant.
Bioinformatics
The generated FASTQ files were demultiplexed by the MiSeq Controller Software, mate-paired using usearch v7.0.1090 [23] and www.advancedsciencenews.com www.mnf-journal.com filtered using usearch with a maximum expected error of 0.5. Chimera checking was performed with usearch against the gold database. [24] UPARSE was used for operational taxonomic unit (OTU) clustering as recommended. [25] Representative sequences were classified using Mothur v.1.25.0 wang() function [26] at 0.8 confidence threshold. Phylogenetic trees were built using the QI-IME 1.7. [27] 3. Results
Fecal Metabolome
Metabolites were extracted from fecal samples and analyzed by 1 H NMR spectroscopy. A representative spectrum of a pooled fecal extract is shown in Supporting Information Figure 2 and the resonance assignments are provided in Supporting Information Table 1 . The lean-seafood diet significantly increased the fecal excretion of trimethylamine (TMA) (p = 0.009, Figure 1 ) with a nearly twofold increase compared to the non-seafood diet.
Gut Microbiome
In order to elucidate the diet-induced modulation of the gut microflora during the non-seafood and lean-seafood interventions, the change of the ratio of Firmicutes and Bacteroidetes during the diet periods were calculated. We observed a trend toward an increased relative abundance of Firmicutes and an accompanying decreased relative abundance of Bacteroidetes after the nonseafood diet period (p = 0.1). On the contrary, the relative abundance of Firmicutes and Bacteroidetes was not affected by the lean-seafood diet period (Figure 2) .
From the 16S rDNA sequencing platform, a total of 1442 operational taxonomic units (OTU) were obtained from the 74 analyzed fecal samples. To reduce the dataset, we set the criteria that bacterial OTU counts must be present in at least half of the total number of samples, which resulted in a dataset with 42 bacterial OTU groups at the genera level, 8 bacterial OTU groups at the family level, 2 bacterial OTU groups at the order level, 1 bacterial OTU group at the class level, and 1 bacterial OTU group at the domain level. Statistical analyses revealed that diet significantly decreased the level of the OTU assigned to Clostridium cluster IV (p = 0.01, Figure 3) following the non-seafood diet period.
Relations Between Gut Composition/Activity and Circulating TMAO
Former studies have linked circulating TMAO concentrations, originating from meat-derived compounds, with atherosclerosis and CVD, [15] and there is therefore an interest in understanding determinants of circulating TMAO. [28] We measured fasting serum TMAO levels before and after the non-seafood intervention, and the serum ranges and median are shown in Supporting Information Figure 3 . In order to evaluate the association of circulating TMAO levels after the consumption of the non-seafood diet with specific metabolites and gut microbiota profiles, we build a PLS model using serum TMAO values as y-variable, and fecal NMR spectral data, fasting serum metabolites, and OTUs (labelled with lowest taxonomic rank available) as x-variables. To remove "unimportant" information, we did variable selection based on VIP scores, and included only variables with a VIP score >1, which have been suggested to cover the "important" variables. [29] Thus, a resultant PLS model, including a total of 31 variables, was constructed (Q 2 = 0.51), and a linear correlation was obtained ( Figure 4A , R 2 = 0.88). Of the variables with a VIP score >1 (Figure 4B ), we observed that circulating TMAO were correlated with OTUs corresponding to bacteria belonging to the order of Clostridiales, Desulfovibrionales, and Erysipelotrichales within the Firmicutes and Proteobacterium phyla of which were Oscillibacter, Clostridium clusters XVIII, Holdemania, Table 1 . Pearson correlation coefficients between serum CVD risk factors (TAG, total to HDL cholesterol ratio) and bacterial 16S rRNA sequencing data. 
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Correlations Between Fecal Metabolites and 16S rDNA Data
In order to examine the contribution of the gut microbiota to variations in fecal metabolites, fecal metabolites were correlated using Pearson correlations with the 16S rDNA microbial data, and a number of significant correlations were identified, which are summarized in Supporting Information Table 2 .
Correlations Between CVD Risk Factors and 16S rDNA Data
As previously observed by Aadland et al., the lean-seafood diet significantly reduced CVD risk factors compared to the nonseafood diet. [16] In order to evaluate the contribution of the gut microbiota on the modulation of CVD risk factors, circulating TAG and the total to HDL cholesterol ratio were correlated with the 16S rDNA microbial data using Pearson correlations. Of the significant correlations identified, Roseburia, Sutterella, and Erysipelotrichaceae were positively correlated with the total to HDL cholesterol ratio; Ruminococcaceae, Clostridia, Bifidobacterium, Faecalibacterium, and Parasutterella were negatively correlated with the total to HDL cholesterol ratio; Anaerotruncus and Asaccharabacter were negatively associated with serum TAG levels; and Turicibacter and Dialister were positively and negatively, respectively, correlated with serum TAG levels and the total to HDL cholesterol ratio ( Table 1) .
Discussion
Metabolomics data from human studies often reveal large biological variation between subjects, [30] and the fecal metabolome www.advancedsciencenews.com www.mnf-journal.com also show considerable interindividual metabolite variation. [22, 31] In the present study, we used a paired structure in the crossover design to reduce this biological variation. Despite large interindividual variation, our results show that 4 weeks of dietary intervention with lean-seafood or non-seafood protein sources modulates the gut microbiota composition in healthy humans. Previously, we demonstrated that the lean-seafood diet, as opposed to the non-seafood diet, significantly reduced circulating TAG and prevented elevation of the total to HDL cholesterol ratio after 4 weeks of intervention. [16] Elevated circulating TAG and the total to HDL cholesterol ratio have been considered strong CVD risk factors. [32] [33] [34] In the current study, we correlated these CVD risk factors with the 16S rDNA microbial data in order to evaluate the contribution of the gut microbiota on the modulation of serum lipids, and found that circulating TAG levels and the total to HDL cholesterol ratio were significantly correlated with specific gut bacteria. Of the gut bacteria identified, some bacteria (Roseburia, Turicibacter, Sutterella, Erysipelotrichaceae) were positively associated, while others (Ruminococcaceae, Dialister, Clostridia, Anaerotruncus, Asaccharabacter, Bifidobacterium, Faecalibacterium, Parasutterella) were negatively associated with CVD risk factors. Other studies have also established significant correlations between specific gut bacteria and various metabolic markers, including insulin resistance [35] and obesity. [36] Furthermore, several studies have identified an association between changes in the gut microbiota composition and various human diseases. [37] [38] [39] However, despite the large number of studies that link gut microbiota alterations to various metabolic markers, no unanimous conclusions on specific gut bacteria and their mechanistic impact on metabolic markers have currently been obtained. In addition, the gut microbiota is influenced by other factors than diet, [40, 41] which add further complexity to the evaluation of specific gut bacteria in relation to health. The current findings suggest that CVD risk factors are correlated with specific gut bacteria, however, in order to determine actual causal associations between circulating TAG and total to HDL cholesterol ratio and specific bacteria, further studies are warranted.
In the intestine, the gut microbiota can generate various metabolites, [42] of which some metabolites might be absorbed while other will be excreted. In order to evaluate the contribution of the gut microbiota to variations in fecal metabolite generation in the present study, fecal metabolites were correlated with the 16S rDNA microbial data. Of the identified correlations, fecal TMA excretion was positively correlated with Bacteroides and Parabacteroides. Intriguingly, in a human study, Zhang et al. identified bacterial genera containing genes encoding for enzymes involved in the conversion of choline to TMA, including Bacteroides and Parabacteroides, [43] which support the assumption that Bacteroides spp. and Parabacteroides spp. might produce TMA. In the present study, we found a higher fecal level of TMA after consumption of the lean-seafood diet compared to after the non-seafood diet. Previously, we found that the content of TMAO in the lean-seafood diet was significantly higher than in the non-seafood diet, [17] and since TMAO serves as an electron acceptor in anaerobic bacterial respiration, [44] free TMAO consumed from the diet is susceptible to be reduced to TMA by anaerobic bacteria in the gut. Hence, the higher fecal level of TMA observed after consumption of the lean-seafood diet is most likely due to this bacterial degradation of dietary-derived TMAO with resultant TMA production.
Besides deriving from dietary origin, TMAO can also be generated from nutrients including choline and carnitine, which is abundant in eggs and beef. This pathway of TMAO generation is dependent on gut bacterial TMA-lyase, which produces TMA that is subsequently absorbed and oxidized by the hepatic enzyme flavin-containing monooxygenase 3 (FMO3). However, lean fish consumption, a major dietary source of TMAO, yields 50 times higher circulating concentrations of TMAO compared to beef and eggs. [45] High circulating TMAO levels have been associated with CVD. [46, 47] However, whether TMAO is the harmful player itself has been questioned. Recently, it was shown in mice that high FMO3 activity, rather than the TMAO concentration itself, was the underlying mechanism to the development of metabolic dysfunctions. [48] Furthermore, the increased risk of atherosclerosis may be associated with the abundance of TMA-producing bacteria in the gut, and hence indirectly with the TMAO generated by oxidation of TMA in the liver, as suggested by Cho et al. [45] Moreover, as fish is a major dietary source of free TMAO, and since the serum TMAO level increases rapidly after fish consumption, indicative of a direct uptake of free TMAO, [45] it seems paradoxical that a high intake of fish in the diet reduces the risk of CVD. [16, 49] Recently, Krüger et al. examined factors of importance for circulating TMAO levels based on data from a cohort study. They found that only a minor variation in circulating TMAO levels could be ascribed to diet and anthropometric factors, and about 75% of the variation in TMAO remained unexplained. [28] However, Krüger et al. did not include data on the gut microbiota composition. In the present study, we were able to establish a linear relationship of circulating TMAO levels, measured before and after the non-seafood diet period, predicted from fecal NMR spectral data, fasting serum metabolites, and OTUs, and thereby examine the contribution from the gut microbiota composition and activity to variations in circulating TMAO levels under standardized and controlled dietary conditions. We found that circulating TMAO levels were associated with fecal TMA and specific gut bacteria belonging to the order of Clostridiales, Desulfovibrionales, and Erysipelotrichales within the Firmicutes and Proteobacterium phyla. Gene clusters for the main TMA-synthesis pathways encoding choline TMA-lyase and carnitine oxygenase have been identified in gut bacteria, and covers bacterial species from the Proteobacteria, Actinobacteria, and Firmicutes phyla, but seems to be absent in bacterial species from the Bacteroidetes phylum. [50, 51] Thus, our findings suggest that circulating TMAO levels are associated with distinct gut microbiota profiles that might be involved in the regulation of serum TMAO, which is consistent with the results observed by Cho et al. [45] Firmicutes and Bacteroidetes cover the two dominant phyla in the human gut and studies have shown an increased proportion of Firmicutes and accompanying lower Bacteroidetes proportions in obese human and mice models compared to lean controls. [52, 53] The obese-coupled gut microbiome has been associated with increased capacity for energy harvest from the diet. [54] Also a Western-style diet, high in fat and sugar, induced a change in the gut microbiota of humanized mice toward an increased relative abundance of the Firmicutes and decreased abundance of Bacteroidetes. [55] In the current study, a trend toward a shift in the ratio of Firmicutes to Bacteroidetes toward a higher relative www.advancedsciencenews.com www.mnf-journal.com abundance of Firmicutes was observed, with an accompanying decrease in the relative abundance of Bacteroidetes. On the contrary, the ratio of Firmicutes to Bacteroidetes was maintained during the lean-seafood intervention. Thus, these findings could indicate that dietary protein of lean-seafood and non-seafood origin differentially modulates the gut microbiome. However, further studies are needed in order to establish a causal association between the consumption of non-seafood proteins and shifts in the Firmicutes/Bacteroidetes ratio.
The gut microbiome also revealed a decreased relative abundance of Clostridium clusters IV following the non-seafood intake as compared to the lean-seafood diet period. Bacterial species within the Clostridium clusters IV have been linked to butyrate production. [56, 57] Butyrate is a crucial metabolite in the human gut as it serves as an energy source for colonocytes and contributes to maintenance of the gut barrier functions, [58] and butyrate supplementation has been shown to protect mice fed with a high-fat diet from insulin resistance. [59, 60] Furthermore, in obese subjects, a weight loss period significantly increased the abundance of Clostridium clusters IV together with a decreased Firmicutes/Bacteroidetes ratio. [61] Thus, our findings show that nonseafood intake decreases the relative abundance of Clostridium clusters IV, which might indicate a potential reduction in butyrateproducing members of the gut microbial community and potential health risk.
In conclusion, the present study revealed that 4 weeks of dietary intervention with lean-seafood or non-seafood sources induced changes in the gut microbiota composition. Following lean-seafood intake, fecal excretion of trimethylamine was significantly increased, which could be assigned to dietary content of TMAO present in the lean-seafood diet. A trend toward a shift in the ratio of Firmicutes and Bacteroidetes toward a higher relative abundance of Firmicutes and accompanying lower abundance of Bacteroidetes was observed after the non-seafood diet. Furthermore, a decreased relative abundance of Clostridium clusters IV was observed following non-seafood intake. On the contrary, the lean-seafood diet period affected neither the ratio of Firmicutes/Bacteroidetes nor the relative abundance of Clostridium clusters IV. Thus, these findings indicate that lean-seafood and non-seafood intake differentially modulates the gut microbiome. Furthermore, the gut microbiota composition seems to affect circulating TMAO levels and CVD risk factors.
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